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Abstract
Background: There is no consensus about the possible relation between in-hospital mortality in
surgery for gastric cancer and the hospital annual volume of interventions. The objectives were to
identify factors associated to greater in-hospital mortality for surgery in gastric cancer and to
analyze the possible independent relation between hospital annual volume and in-hospital mortality.
Methods: We performed a retrospective cohort study of all patients discharged after surgery for
stomach cancer during 2001–2002 in four regions of Spain using the Minimum Basic Data Set for
Hospital Discharges. The overall and specific in-hospital mortality rates were estimated according
to patient and hospital characteristics. We adjusted a logistic regression model in order to calculate
the in-hospital mortality according to hospital volume.
Results: There were 3241 discharges in 144 hospitals. In-hospital mortality was 10.3% (95% CI
9.3–11.4). A statistically significant relation was observed among age, type of admission, volume,
and mortality, as well as diverse secondary diagnoses or the type of intervention. Hospital annual
volume was associated to Charlson score, type of admission, region, length of stay and number of
secondary diagnoses registered at discharge. In the adjusted model, increased age and urgent
admission were associated to increased in-hospital mortality. Likewise, partial gastrectomy (Billroth
I and II) and simple excision of lymphatic structure were associated with a lower probability of in-
hospital mortality. No independent association was found between hospital volume and in-hospital
mortality
Conclusion: Despite the limitations of our study, our results corroborate the existence of patient,
clinical, and intervention factors associated to greater hospital mortality, although we found no
clear association between the volume of cases treated at a centre and hospital mortality.
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Background
Importance of gastric cancer
Stomach cancer is the second most common malignancy
of the digestive tract in developed countries [1]. In Spain,
the incidence adjusted to the worldwide population
ranges from 12.2 to 21.6 cases per 100 000 men, depend-
ing on the region; the incidence in women is slightly less
than half that of men. Surgery and chemotherapy are the
mainstays of treatment. However, surgery is associated
with considerable morbidity and lesser though significant
mortality. The few studies published on morbidity and
mortality after surgery for gastric cancer report variable
rates [2-4].
In Spain, gastric cancer surgery is performed in many types
of hospitals and in all regions. On the other hand, there is
no specific register that facilitates the assessment of proc-
ess and outcomes of surgical interventions.
Outcomes study and in-hospital mortality
In-hospital mortality has often been considered an out-
come indicator directly related with the quality of care [5].
Because in-hospital mortality is an objective measure-
ment that is readily available in hospital databases, it has
been used to analyze and compare outcomes among dif-
ferent centres. However, to ensure valid comparison, it is
necessary to adjust the rates by taking patients' baseline
risk or comorbidities into account [6,7]; thus, different
methods have been validated to be used with administra-
tive databases with codes for diagnoses and procedures
[8,9]. In the absence of specific registers, administrative
databases are the main alternative for this kind of evalua-
tion.
Factors associated to in-hospital mortality in gastric 
cancer
In addition to patients' baseline condition, aspects related
to the structure of the hospital, the experience of the pro-
fessionals involved, and the surgical procedure itself can
affect surgical outcomes. Likewise, a centre's volume of
activity for a given type of surgical procedure, especially
for cardiovascular and oncological interventions, has also
been reported to affect post-operative mortality in several
studies [10-14]. However, some recent studies question
the relationship between volume of activity and outcome;
the authors of these studies point out that even if
increased volume of activity were responsible for better
outcome, the mechanisms underlying improved out-
comes are not clear [13,15,16]. On the other hand, differ-
ent definitions and cut-off points referring to hospital
volume could be responsible for the divergent results
found among different studies.
Study justification
Given the relatively high rate of in-hospital mortality for
gastric cancer reported by various authors, the scarcity of
studies that analyze the surgical outcomes of this malig-
nancy in Spain, and the controversies related to the possi-
ble association between volume of activity and outcomes,
this study aimed to: 1. estimate the in-hospital mortality
in surgery for gastric cancer in different regions in Spain;
2. identify factors associated to greater in-hospital mortal-
ity; 3. analyze the possible relation between volume and
in-hospital mortality.
Methods
Design, setting, patients, and source of information
We performed a retrospective cohort study (based on
administrative database) of all patients discharged after
surgery for stomach cancer during 2001 and 2002 in four
regions of Spain. These regions represent about 52% of
the total population. In Spain, there is neither a common
oncological surgical registry nor a National Cancer Regis-
try. For many years, all hospital discharges are homoge-
nously recorded and centralized at the Department of
Health in each of the 17 Autonomous Communities or
regions in the administrative database called Minimum
Basic Data Set for Hospital Discharges (MBDS-HD). This
database contains the following information: date of
birth, gender (male or female), type of admission (urgent
or scheduled), destination on discharge (dead or alive),
International Classification of Diseases 9th revision Clini-
cal Modification (ICD9CM) [17] codes for the main and
secondary diagnoses, ICD codes for the main and second-
ary procedures performed, date of admission, and date of
discharge.
We included all discharges corresponding to patients with
a principal diagnosis of stomach cancer (ICD code:
151.XX) that had undergone total or partial gastrectomy
(ICD code: 43.5–43.9).
Groundwork with experts: proposing factors
Secondary diagnoses were grouped into 259 mutually
exclusive categories using the Clinical Classifications Soft-
ware (CCS) [18] developed by the Center for Organiza-
tion and Delivery Studies in the Healthcare Cost and
Utilization Project (HCUP) at the Agency for Healthcare
Research and Quality (AHRQ).
To pre-select factors that might be associated to in-hospi-
tal mortality, we contacted oncologists, gastroenterolo-
gists, and surgeons from different centres. We asked them
to propose a list of surgical factors, patient comorbidities,
factors related to the severity of disease, and complica-
tions that they considered might increase the probability
of in-hospital death during or after surgery. The possible
factors suggested and corresponding ICD codes are listed
in Appendix 1. Although the stage of the tumour was
among the factors proposed, it was not included in the
study because the MBDS-HD does not include a specificBMC Public Health 2009, 9:312 http://www.biomedcentral.com/1471-2458/9/312
Page 3 of 14
(page number not for citation purposes)
code for this factor and no population cancer registry was
available.
The study was approved by the institutional review board
of the Corporació Sanitària del Parc Taulí.
Variables analyzed
Apart from the factors listed in the appendix, the follow-
ing variables were considered: age group (≤50, 51–64, 65–
74, 75–84, ≥ 85), gender, region, type of admission as
recorded in the MBDS-HD (urgent or elective), and vol-
ume of discharges analyzed for each hospital. For each
admission, the Charlson score was calculated from the
codes for the secondary diagnoses using the Deyo [8]
adaptation; each case was then grouped into one of four
categories (0, 1, 2, > 2). We calculated the length of stay
for each admission. We also created the variable 'number
of secondary diagnosis coded' for each discharge, which
was later recoded into the categories ≤ 3, 4–5, and ≥ 6.
Definition of in-hospital mortality and hospital volume
In-hospital mortality was defined as death occurring dur-
ing the hospital stay. The annual volume of discharges
was defined as the mean number of discharges included
in the study at a given centre per year. Annual volume of
discharges was grouped into three categories according to
terciles (<18, 18–35, >35) and into 7 volume categories
corresponding to smaller ranges consisting of 10 dis-
charges each.
Statistical analysis
The unit of analysis was the hospital discharge. We carried
out a descriptive analysis of all variables of interest. The
overall and specific in-hospital mortality rates for stom-
ach cancer were estimated as a function of the admission
type, age group, gender, region, annual volume of dis-
charges, CCS diagnoses selected, and type of surgical pro-
cedure. The 95% confidence intervals were calculated for
the overall rate according to the normal approximation.
The chi-square or the Fisher's exact test was used to deter-
mine whether the factors studied were associated to mor-
tality. Then, the same type of analysis was used to
compare some variables of interest (age, gender, mortal-
ity, Charlson score, type of admission, region), as a func-
tion of the 3 annual volume categories. We used the
Kruskal-Wallis test to compare the mean number of sec-
ondary diagnoses registered per discharge and the mean
length of stay.
Then, a logistic regression model was constructed to deter-
mine whether the different demographic (age, region),
admission factors (urgent, number of secondary diag-
noses), or comorbidities studied (Charlson, congestive
heart failure, pancreatic disorders, cardiac dysrhythmias,
nutritional deficiencies, gastrointestinal haemorrhage,
other gastrointestinal disorders, invasion of other struc-
tures) were independently associated to the adjusted mor-
tality. Only those secondary diagnoses considered
comorbidities by the experts and not included in the
Charlson score were considered for the model, so possible
complications occurring as a consequence of the interven-
tion were not included (see appendix 1). First, we selected
variables present in more than 1% of cases (more than 30
cases) that had p values < 0.1 in the univariate analysis.
Next, we used the forward conditional stepwise method to
construct the model. The odds ratios and 95% confidence
intervals were calculated. Finally, goodness of fit was eval-
uated by the Hosmer-Lemeshow X2 statistic [19] and the
area under the receiver operator characteristic (ROC)
curve was calculated to assess the discriminative capacity
of the model. Values ranging from 0.7 to 0.8 represent rea-
sonable discrimination and values exceeding 0.8 repre-
sent good discrimination [20].
We evaluated the association between hospital volume
and adjusted mortality by introducing the variable annual
hospital volume (3 categories) in the logistic regression
model and estimating its odds ratios and 95% confidence
intervals.
We considered p < 0.05 significant for all tests. The SPSS
15.0 statistical package was used for all analyses.
Results
During 2001 and 2002, there were 3241 discharges of
patients operated on for stomach cancer in the four
regions analyzed. Nearly two thirds of the discharges cor-
responded to men and the predominant age group was
65–75 years old (see table 1).
Median hospital stay (LOS) was 19 days (mean 25 (18);
range 1–291 in the 144 hospitals included, and it was
higher for urgent admissions than for elective ones
(median 29 vs 15, p < 0.001). Crude in-hospital mortality
was 10.3% (95% CI 9.3–11.4). No statistically significant
differences in mortality were observed between regions
(see table 1). A statistically significant relation was
observed among age, type of admission, volume, and
mortality. Statistically significant associations were found
between mortality and several clinical factors, such as res-
piratory or renal failure, electrolyte disorders, acute myo-
cardial infarction, peritonitis and intestinal abscess,
congestive heart failure (CHF), cardiac dysrhythmia, gas-
trointestinal haemorrhage, or diverse complications of
surgical procedures (tables 2 and 3). Mortality was signif-
icantly higher in tumours located in the fundus or cardia of
stomach (p = 0.001). A trend toward higher mortality
with higher volume was observed only in fundus or cardia
tumours. Mortality was significantly lower in partial gast-
rectomy with anastomosis to the duodenum (Billroth I),
and in simple or even in radical excision of lymphatic
structures (lymphadenectomy) than in other surgical pro-BMC Public Health 2009, 9:312 http://www.biomedcentral.com/1471-2458/9/312
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cedures, but only in locations other than the cardia or fun-
dus.
The Charlson index, the type of admission, the region, the
number of secondary diagnosis registered, and the LOS
were significantly associated to annual volume (Table 4).
Thus, we found a greater proportion of patients with
Charlson scores greater than or equal to 3 in hospitals per-
forming more interventions compared to those perform-
ing fewer interventions. The proportion of urgent
admissions and the LOS also increased with higher vol-
ume of interventions. Likewise, the higher the annual vol-
ume of interventions, the higher the number of secondary
diagnoses recorded. Finally, hospital mortality was also
significantly lower in the hospitals with lower volume of
interventions.
In the regression model (table 5), increased age and
urgent admission were independent risk factors for in-
hospital mortality. Likewise, CHF and cardiac dysrhyth-
mias were associated to an increased probability of dying
in the hospital, while Billroth I and II interventions (par-
tial gastrectomies with anastomosis to duodenum or jeju-
num), as well as simple lymphadenectomy were
associated to a decreased probability of dying in the hos-
pital. The Hosmer-Lemeshow statistic was 2.025 (p =
0.980) and the area under the ROC curve 0.772 (95%CI
0.747 – 0.797).
Despite the association found between annual volume
and crude in-hospital mortality, no specific pattern of
crude in-hospital mortality was observed after grouping
centres in smaller volume categories (see figure 1). In the
logistic regression model, hospital volume grouped by ter-
ciles was not independently associated with mortality
after adjusting for other factors.
The Odds Ratios for in-hospital mortality, adjusted for the
variables included in the regression model and using the
smaller volume categories, are shown in figure 2. Again,
we observed no trend or pattern that would enable a pos-
sible relation between volume and in-hospital mortality
to be identified.
Discussion
The in-hospital mortality rate in patients that underwent
surgery for stomach cancer during 2001 and 2002 was
greater than 10% in the overall set of regions evaluated.
Older patient age, urgent admission, and certain comor-
bidities were significantly associated to greater mortality.
Certain surgical procedures, such as Billroth I and II were
associated to lower mortality. We found no relation
between volume and in-hospital mortality.
Comparison with past literature
Differences in study periods and the definition of mortal-
ity used (such as post-operative mortality, 30-day mortal-
ity, or in-hospital mortality) among the different studies
published limits the comparability of results. Moreover,
some studies, such as ours, did not adjust mortality rates
for severity factors, such as tumour stage at diagnosis.
Despite these limitations, we can say that the in-hospital
mortality rate observed in our study was high, although it
was within the range of 1.7% to 12% reported by other
authors [2,21,22]. McCulloch et al. reported the exact
same mortality rate in 4 years as found in our study [23].
Furthermore, the wide range of variability among hospi-
tals in our study might be partly due to differences in the
factors that we found were associated, as the estimations
of the adjusted odds ratios for mortality at the different
centres grouped according to volume (figure 2) are similar
and their confidence intervals overlap.
Hospital mortality and quality of care
Mortality has been defended as an indicator of the quality
of care in hospitals. In fact, mortality is an objective, reli-
able, precise, and bias-free measure that can be the direct
consequence of substandard care; however, a high mortal-
ity rate does not always indicate poor quality and poor
quality does not always result in greater hospital mortality
Table 1: Hospital mortality according to socio-demographic and 
admission variables.
Patients In-hospital mortality
nC o l  % n R o w  % p - v a l u e
Gender
Male 2055 63.4 220 10.7 0.32
Female 1186 36.6 114 9.6
Age group
≤ 50 331 10.2 6 1.8 <0.01
51–64 770 23.8 48 6.2
65–74 1093 33.7 100 9.1
75–84 894 27.6 142 15.9
≥ 85 153 4.7 38 24.8
Region
A1 420 13.0 44 10.5 0.10
B 1249 38.5 113 9.0
C 1058 32.6 128 12.1
D 514 15.9 49 9.5
Admission type
Urgent 970 29.9 147 15.2 <0.01
Elective 2271 70.1 187 8.2
Hospital volume
<18 1145 35.3 90 7.9 0.003
18–35 1050 32.4 123 11.7
>35 1046 32.3 121 11.6
Charlson score
0 1576 48.6 153 9.7 0.05
1 516 15.9 55 10.7
21 1 8 3 . 6 2 1 1 7 . 8
≥ 3 1031 31.8 105 10.2
1 Only 2001 dataBMC Public Health 2009, 9:312 http://www.biomedcentral.com/1471-2458/9/312
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[24]. In the United States, the Agency for Healthcare
Research and Quality (AHRQ) has approved the use of
hospital mortality rates for 8 surgical procedures as crite-
ria of quality and possible referral of patients to other cen-
tres [25]. These 8 procedures were selected because of
their high mortality and because of the high variability in
mortality among the different hospitals that they ana-
lyzed. Nevertheless, as Dimick et al. point out, the low fre-
quency of some of these 8 surgical procedures at some
centres raises the question whether it is appropriate to use
mortality rates as a measure of quality in all cases [5].
Table 2: Hospital mortality according to clinical factors.
Patients In-hospital mortality
N n Row % p-value
Secondary diagnosis
Respiratory failure, insufficiency, arrest (adult) No 3071 227 7.4 <0.01
Yes 170 107 62.9
Renal failure No 3159 285 9.0 <0.01
Yes 82 49 59.8
Fluid and electrolyte disorders No 3209 316 9.8 <0.01
Yes 32 18 56.3
Acute myocardial infarction No 3234 330 10.2 <0.01
Yes 7 4 57.1
Peritonitis and intestinal abscess No 3123 282 9.0 <0.01
Yes 118 52 44.1
Congestive heart failure, non-hypertensive No 3173 310 9.8 <0.01
Yes 68 24 35.3
Pancreatic disorders (not diabetes) No 3213 326 10.1 <0.01
Yes 28 8 28.6
Pneumonia No 3131 304 9.7 <0.01
Yes 110 30 27.3
Cardiac dysrhythmias No 3047 286 9.4 <0.01
Yes 194 48 24.7
Nutritional deficiencies No 3215 328 10.2 0.03
Yes 26 6 23.1
Complications of surgical procedures or medical care No 2302 121 5.3 <0.01
Yes 939 213 22.7
Gastrointestinal haemorrhage No 3079 303 9.8 <0.01
Yes 162 31 19.1
Intestinal obstruction without hernia No 3192 325 10.2 0.06
Yes 49 9 18.4
Other gastrointestinal disorders No 3097 309 10.0 <0.01
Yes 144 25 17.4
Diabetes mellitus with complications No 3215 330 10.3 0.39
Yes 26 4 15.4
Invasion of others structures No 2840 273 9.6 <0.01
Yes 401 61 15.2
Phlebitis, thrombophlebitis, and thromboembolism No 3190 328 10.3 0.73
Yes 51 6 11.8
Hypertension No 2576 273 10.6 0.28
Yes 665 61 9.2
Urinary tract infections No 3159 334 10.6 <0.01
Yes 82 0
Diverticulosis and diverticulitis No 3184 334 10.5 0.01
Yes 57 0
Anatomic localization of the tumour volume
Cardia/Fundus <18 106 12 11.3 0.14
18–35 99 14 14.1
>35 115 21 18.3
Other/unspecified <18 1039 78 7.5 0.01
18–35 951 109 11.5
>35 931 100 10.7BMC Public Health 2009, 9:312 http://www.biomedcentral.com/1471-2458/9/312
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Study implications and limitations
From the information available in our study, it is difficult
to deduce what aspects of the process of care (details
about surgical management, for instance) have led to
complications such as peritonitis, kidney failure, or respi-
ratory failure, and this makes it difficult to take action to
improve the quality of care. Likewise, suture failure can
occur after technically impeccable surgery, because it
depends to a certain extent on other factors such as the
patient's nutritional and/or immune status. This is one
limitation of hospital mortality studies that use adminis-
trative databases if the aim is to use the results to improve
the process of care.
Furthermore, as some authors have already noted, admin-
istrative databases also have limitations for adjusting
patients' baseline risks to enable comparisons of mortality
rates [26-29]. These limitations are related to a) differ-
ences in (or the lack of) coding for some comorbidities or
procedures and the consequent possibility of under-cod-
ing of diagnoses in patients with greater severity (for
example, the variable relative to nutritional deficiencies),
b) the misclassification of certain health problems, c) the
failure to register some variables of known clinical impor-
tance (for example, the clinical stage of the tumour or
indicators of the patient's pre-operative physiological
state, which is of key importance in surgical patients
[30,31]), and d) the difficulty in distinguishing among
health problems that were present before admission from
those that might have resulted from complications of the
healthcare process.
We used in-hospital mortality as the outcome variable in
the study because it was the only mortality variable avail-
able in the administrative databases; however, using this
outcome variable can lead to limitations in interpreting
differences in mortality. For instance, in-hospital mortal-
ity would probably be higher in centers that prolong LOS
than in centers with a policy to discharge patients earlier.
Patients discharged earlier might die within 30 days of dis-
charge and this would result in an underestimation of sur-
gical mortality. Table 4 shows that LOS was lower in
centers with a lower volume of interventions, and this
could partially explain the lower in-hospital mortality in
those centers. As mentioned above, the different studies
published use different definitions of mortality; Table 6
shows the most recent results about volume of interven-
tions and short-term mortality for gastric cancer.
According to our data, it is evident that the specific loca-
tion of the tumour is also often under coded and that the
mean number of secondary diagnoses registered varies
among different hospital volumes. In our study, patients
who died in hospital had a higher number of secondary
Table 3: Hospital mortality according to surgical procedure.
Patients In-hospital mortality
Nn R o w  % p - v a l u e
Procedures by anatomic localization
Cardia/Fundus Regional lymph node excision No 302 46 15.2 0.49
Yes 18 1 5.6
Radical excision of other lymph nodes No 299 47 15.7 0.05
Yes 21 0
Simple excision of lymphatic structure No 308 47 15.3 0.23
Yes 12 0
Partial gastrectomy with anastomosis to oesophagus (proximal) 18 3 20.0 0.51
Other partial gastrectomy 27 1 3.7
Total gastrectomy 250 38 15.2
Partial gastrectomy with anastomosis to jejunum (Billroth II) 20 4 20.0
Partial gastrectomy with anastomosis to duodenum (Billroth I) 5 1 20.0
Other/Unspecified
Regional lymph node excision No 2805 278 9.9 0.44
Yes 116 9 7.8
Radical excision of other lymph nodes No 2732 277 10.1 0.03
Yes 189 10 5.3
Simple excision of lymphatic structure No 2791 284 10.2 <0.01
Yes 130 3 2.3
Partial gastrectomy with anastomosis to oesophagus (proximal) 7 2 28.6 0.01
Other partial gastrectomy 590 72 12.2
Total gastrectomy 1096 111 10.1
Partial gastrectomy with anastomosis to jejunum (Billroth II) 984 89 9.0
Partial gastrectomy with anastomosis to duodenum (Billroth I) 244 13 5.3BMC Public Health 2009, 9:312 http://www.biomedcentral.com/1471-2458/9/312
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diagnoses, and this confirms a certain register bias that
favours patients who die in the hospital. On the other
hand, the absence of tumour stage, a key factor for the
patient's prognosis (especially long-term prognosis), is an
evident limitation. We would expect only patients with
the most advanced stages (although with the possibility of
being cured by surgery, as in our study) to have a greater
risk of in-hospital death after the intervention. Finally,
some authors have advocated tumour resection with rad-
ical lymph-node excision (D2), claiming that long-term
outcomes (survival) are better than with more conserva-
tive surgery (D1), although D2 also has greater post-oper-
ative morbidity and mortality that counteracts the
possible benefits [32,33]. The coding system used for the
MBDS-HD, the ICD9CM, does not allow us to distinguish
between these specific aspects of the care process, not only
because of possible under coding, but also because of the
lack of specific codes for this or other procedures.
Many of the limitations of this study derive from the fact
that compiling homogeneous, highly reliable, and spe-
cific information is impossible due to the lack of informa-
tion systems and specific clinical registers for oncological
surgery in Spain, and this problem obviously needs to be
tackled. Otherwise, it will be practically impossible to
completely analyze the process of care and outcomes for
oncological surgery that will enable us to take measures to
improve the quality of care.
Even with the possible limitations, we have been able to
determine that mortality is greater for tumours located in
the fundus or even in the cardia; many tumours of the fun-
dus also invade the cardia. Also, we have observed a lower
crude mortality following a Billroth I than after a Billroth
II in tumours located outside the cardia or fundus. In cases
in which a Billroth I was used, we assume that it was a
small tumour and that the patient could benefit, leading
to low in-hospital mortality.
Administrative databases like the one used in this study
are currently the only source of information that is com-
mon to all centres, homogeneous, accessible, and consid-
erably exhaustive; they contain epidemiological and
clinical information about the hospital discharges for a
given diagnosis in the Spanish healthcare system and in
those of many other countries [34]. Moreover, in-hospital
Table 4: Patient or admission factors according to annual hospital volume.
Hospital volume
<18 Col % 18 – 35 Col % >35 Col % p-value
In-hospital mortality Yes 90 7.9 123 11.7 121 11.6 0.003
No 1055 92.1 927 88.3 925 88.4
Gender Male 731 63.8 670 63.8 654 62.5 0.772
Female 414 36.2 380 36.2 392 37.5
Age group ≤ 50 128 11.2 108 10.3 95 9.1
51–65 270 23.6 249 23.7 251 24.0
65–75 386 33.7 344 32.8 363 34.7 0.778
75–84 314 27.4 293 27.9 287 27.4
≥ 85 47 4.1 56 5.3 50 4.8
Charlson score 0 662 57.8 482 45.9 432 41.3
1 173 15.1 164 15.6 179 17.1 0.000
2 3 53 . 13 23 . 05 14 . 9
≥ 3 275 24.0 372 35.4 384 36.7
Admission type Urgent 265 23.1 346 33.0 359 34.3 0.000
Elective 880 76.9 704 67.0 687 65.7
Region A 179 15.6 159 15.1 82 7.8
B 589 51.4 443 42.2 217 20.7 0.000
C 227 19.8 273 26.0 558 53.3
D 150 13.1 175 16.7 189 18.1
Num. of secondary diagnoses Mean (sd) 2.9 (2.4) 3.7 (2.7) 4.7 (2.9) 0.000*
Length of Stay (LOS) Median 16 21 21 0.000*
Total 1145 1050 1046
*Kruskal-Wallis test.BMC Public Health 2009, 9:312 http://www.biomedcentral.com/1471-2458/9/312
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Table 5: Multivariate logistic regression model of in-hospital mortality.
p-value OR 95% CI OR
Lower Upper
Simple excision of lymphatic structure ,005 ,189 ,058 ,611
Billroth I ,001 ,379 ,212 ,677
Billroth II ,002 ,651 ,496 ,853
Age ,000
51–65 3,237 1,359 7,714
65–75 4,383 1,885 10,191
75–84 8,266 3,569 19,141
≥ 85 13,913 5,598 34,574
Type of admission: urgent ,001 1,551 1,208 1,992
Congestive Heart Failure ,003 2,325 1,333 4,056
Cardiac dysrhythmias ,040 1,495 1,019 2,194
Number of secondary diagnoses recorded ,000
4–5 3,410 2,031 5,724
≥ 6 8,691 5,154 14,656
Hospital volume ,242
18–35 1,285 ,949 1,741
>35 1,245 ,892 1,736
Reference categories: simple excision of lymphatic structure (no); Billroth I (no); Billtroth II (no); age (≤ 50); type of admission (elective); number of 
secondary diagnosis (≤ 3); hospital volume (≤ 17); region (A). Adjusted by region.
OR: Odds Ratio
In-hospital mortality rates of the centres grouped according to annual volume of discharges Figure 1
In-hospital mortality rates of the centres grouped according to annual volume of discharges.
61 + 51-60 41-50 31-40 21-30 11-20 <=10
0,14
0,12
0,10
0,08BMC Public Health 2009, 9:312 http://www.biomedcentral.com/1471-2458/9/312
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mortality is a highly reliable objective measure that is
available in all of these administrative databases and that
can be monitored over time. Therefore, these databases
can serve as the starting part for the analysis of the quality
of care and detection of possible problems that might
have an impact on hospital mortality.
Hospital volume and in-hospital mortality
We found no independent relation between adjusted hos-
pital mortality and the volume of interventions at a hos-
pital. Moreover, there does seem to be a similarity in the
risk of in-hospital mortality and other indicators (LOS,
Charlson score, urgent admission) among the centres that
performed more than 17 interventions per year.
In a recent prospective study carried out in Scotland,
Thompson et al. also found no relation between hospital
volume and mortality after surgery for stomach cancer
[35]. Two other studies carried out in the United Kingdom
found a very weak relation favouring lower mortality with
greater volume [23,36]. In our study, the univariate anal-
ysis found a statistically significant association between
volume and mortality in the opposite direction to that
hypothesized, so that greater volume was associated to
greater mortality. This tendency was only observed in
tumours located in the cardia or fundus, but it was not sig-
nificant and may be due to the low number of cases. This
possible association was not significant in the multivari-
ate analysis, either; again, this could be due to the low
number of cardia or fundus tumours and the association
found between the type of procedure and mortality for
tumours outside those locations.
In fact, hospitals that treat a larger number of cases might
care for patients with more severe disease and more
comorbidities who have a higher probability of complica-
tions, and this might predispose to a higher mortality rate.
In our study, we identified a significantly higher percent-
age of patients with Charlson score greater than or equal
to 3 (see table 4) in higher volume centres, and a higher
rate of complications of surgical procedures in those cen-
tres (data not shown).
However, some studies of mortality after surgery for stom-
ach cancer have found that university hospitals and those
that treat a greater volume of cases might have lower post-
operative and long-term mortality rates, [10,37-41]
although the results of other studies contradict this
hypothesis or fail to confirm it [3,4,21,35,42-44] and
other authors have questioned this hypothesis with
respect to surgery for other types of cancer [45].
Variation in the Odds Ratios (95%CI) for adjusted* in-hospital mortality in relation to centres with lower volume (≤ 10 dis- charges) Figure 2
Variation in the Odds Ratios (95%CI) for adjusted* in-hospital mortality in relation to centres with lower vol-
ume (≤ 10 discharges). The circle indicates the estimated Odds Ratio (OR), while the vertical lines indicate the 95%CI of the 
OR. * Adjusted for age, type of admission, simple excision of lymphatic structure, Billroth I and Billroth II intervention, conges-
tive heart failure, cardiac dysrhythmias, number of secondary diagnoses recorded, and region.
61 + 51-60 41-50 31-40 21-30 11-20 <=10
1,80
1,50
1,20
0,90
0,60BMC Public Health 2009, 9:312 http://www.biomedcentral.com/1471-2458/9/312
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Despite the limitations in the comparability of the stud-
ies, it seems clear that the results are contradictory and
there is no consensus, as is shown in table 6. It is evident
that the characteristics of the healthcare systems, such as
patient referral practices, centralization of oncological sur-
gery, and the financing of medical procedures varies
widely between the United States, Japan, Canada, and
most European countries in which these questions have
been analyzed. In the Spanish National Healthcare Sys-
tem, all medical procedures are financed by the System
and patients are free to choose the centre where they are
treated. On the other hand, the most complex patients
tend to be treated in the centres that have the most expe-
rience in this type of interventions, so there is a certain
degree of centralization Differences in the degree of cen-
tralization might partially explain the disparity in the cut-
off points used for the volume of interventions in the dif-
ferent studies. Greater centralization can also lead to two
different effects. On the one hand, centres specializing in
a certain intervention are likely to attract more complex or
more severe patients with greater a priori possibilities to
die in the short term; on the other hand, increased volume
Table 6: Original studies about volume of interventions and short-term mortality in stomach cancer (published in English and indexed 
1999–January 2008).
REFERENCE N PERIOD SOURCE VOLUME 
CATEGORIES
MORTALITY
TOTAL % and/or 
(range by 
volume)
DEFINITION ADJUST ASSOC.
Bachmann MO, Br J 
Surg, 2002
405 1996–1997 CDB Terciles 14 operative (≤ 30 
days)
Yes No
Birkmeyer JD, 
Cancer, 2006
9,403 2000–2002 ADB Quintiles 7.3 – 10.1 operative 
(discharge or ≤ 30 
days)
Yes Yes
Birkmeyer JD, N Eng 
J Med, 2002
31,944 1994–1999 ADB Quintiles 8.7 – 13.0 operative 
(discharge
or ≤ 30 days)
No Yes
Callahan MA, Ann 
Surg, 2003
6,434 1998–2001 ADB Quartiles 8.4 (3.7 – 11.3) in-hospital 
(discharge)
Yes Yes
Damhuis RAM, Eur J 
Surg Oncol, 2002
1,978 1987–1997 R <7, 7–10, >10 7.9 (3.1 – 15.1) operative (≤ 30 
days)
Yes No
Finlayson EVA, Arch 
Surg, 2003
16,081 1995–1997 ADB <9, 9–17, >17 6.9 – 8.7 in-hospital 
(discharge)
Yes No
Gordon TA, J Am Coll 
Surg, 1999
705 1989–1997 ADB ≤ 10, 11–20... ≥ 
201
10.9 (6.3 – 12.8)
(total gastrectomy)
in-hospital 
(discharge)
Yes No
Hannan EL, Surgery, 
2002
3,711 1994–1997 ADB Quartiles 6.2 (2.8 – 11.2) in-hospital 
(discharge)
Yes Yes
Hansson LE, Eur J 
Surg, 2000
1,024 1989–1995 CDB Hospital level 12 (10 – 13) in-hospital 
(discharge)
Yes No
Jensen LS, Scand J 
Surg, 2007
537 1999–2004 ADB <5, 5–20, >20 8.2 (8.0 – 8.4) operative 
(discharge
or ≤ 30 days)
No No
Lin HC, Ann Surg 
Oncol, 2006
11,348 2000–2003 ADB Quintiles 1.3 – 5.3 in-hospital 
(discharge)
Yes Yes
McCulloch P, Br Med 
J, 2003
590 1999–2002 CDB ≤ 10, 11–20, ≥ 21 10.3 in-hospital 
(discharge)
Yes Weak
Reid-Lombardo KM, 
J Gastrointest Surg, 
2007
6,047 2001 R Hospital level 5.5 – 9.9 operative (≤ 30 
days)
Yes Yes
Smith JK, Arch Surg, 
2007
13,354 1998–2003 ADB ≤ 4, 5–10, ≥ 11 6 (4.9 – 6.8) in-hospital 
(discharge)
Yes Yes
Smith DL, Ann Surg 
Oncol, 2007
1,864 1999–2001 ADB <3, 3–15, >15 0.8 – 9.5 in-hospital 
(discharge)
Yes Yes
Thompson AM, Br J 
Surg, 2007
1,264 1997–1999 CDB Quartiles 9.1 – 11.9 operative 
(discharge or ≤ 30 
days)
No No
Wainess RM, J 
Gastrointest Surg, 
2003
23,690 1988–2000 ADB Terciles 7.4 (6.5 – 8.3) in-hospital 
(discharge)
Yes No
Xirasagar S, Eur J Surg 
Oncol, 2008
6,909 1997–1999 ADB Quartiles 18.5 – 24.5 6-month Yes No
CDB: Clinical database; ADB: Administrative database; R: Cancer registerBMC Public Health 2009, 9:312 http://www.biomedcentral.com/1471-2458/9/312
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and greater experience are likely to counterbalance these
effects on in-hospital mortality.
Thus, it seems logical that any interpretation of the results
published should take into account not only the compa-
rability of the design of the studies, but also the specific
characteristics of each healthcare system and the time
frame of the observations [46]. Furthermore, it might be a
mistake to consider greater volume as a standard to pre-
dict better quality, when it is more likely the structures,
the experience and specialization of the professionals, and
the many different processes linked to this type of inter-
vention that are responsible for better results, as many
authors have pointed out [47-49].
Conclusion
In conclusion, this is the first study to be carried out in
Spain that used secondary databases to analyze hospital
mortality and possible associated factors after surgery for
gastric cancer. Our results corroborate the existence of
patient and intervention factors associated to greater hos-
pital mortality, although we have found no clear associa-
tion between the volume of cases treated at a centre and
hospital mortality.
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Appendix 1
Clinical Classification Software – DIAGNOSES
(With all coding changes valid from January 1980
through September 2003)
Important: complications (not included in the multivariate
model) are written in bold face
Pneumonia (except that caused by tuberculosis or sexu-
ally transmitted disease)
00322 0203 0204 0205 0212 0221 0310 0391 0521 0551
0730 0830 1124 1140 1144 1145 11505 11515 11595
1304 1363 4800 4801 4802 4808 4809 481 4820 4821
4822 4823 48230 48231 48232 48239 4824 48240
48241 48249 4828 48281 48282 48283 48284 48289
4829 483 4830 4831 4838 4841 4843 4845 4846 4847
4848 485 486 5130 5171
Urinary tract infections
03284 59000 59001 59010 59011 5902 5903 59080
59081 5909 5950 5951 5952 5953 5954 59581 59582
59589 5959 5970 59780 59781 59789 59800 59801
5990
Peritonitis and intestinal abscess
03283 5670 5671 5672 5678 5679 5695
Complications of surgical procedures or medical care
3490 3491 41511 4294 4582 5121 5190 51900 51901
51902 51909 53640 53641 53642 53649 56962 5642
5643 5644 5696 56962 5793 9093 9954 99586 9970
99700 99701 99702 99709 9971 9972 9973 9974 9975
99760 99761 99762 99769 99771 99772 99779 9979
99791 99799 9980 9981 99811 99812 99813 9982 9983
99832 9984 9985 99851 99859 9986 9987 9988 99881
99882 99883 99889 9989 9990 9991 9992 9993 9994
9995 9996 9997 9998 9999
Intestinal obstruction without hernia
5600 5601 5602 56030 56031 56039 56081 56089 5609
Renal failure
5845 5846 5847 5848 5849 586 V420 V451 V560 V561
V562 V5631 V5632 V568 585 7925
Phlebitis, thrombophlebitis and thromboembolism
V1251 V1252 4510 45111 45119 4512 45181 45182
45183 45184 45189 4519 452 4530 4531 4532 4533
4538 4539
Respiratory failure, insufficiency, arrest (adult)
V461 V462 5185 51881 51882 51883 51884 7991
Acute myocardial infarction
4100 41000 41001 41002 4101 41010 41011 41012
4102 41020 41021 41022 4103 41030 41031 41032
4104 41040 41041 41042 4105 41050 41051 41052
4106 41060 41061 41062 4107 41070 41071 41072
4108 41080 41081 41082 4109 41090 41091 41092BMC Public Health 2009, 9:312 http://www.biomedcentral.com/1471-2458/9/312
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Pancreatic disorders (not diabetes)
5770 5771 5772 5778 5779 5794
Hypertension
4011 4019 4010 40200 40201 40210 40211 40290
40291 4030 40300 40301 4031 40310 40311 4039
40390 40391 4040 40400 40401 40402 40403 4041
40410 40411 40412 40413 4049 40490 40491 40492
40493 40501 40509 40511 40519 40591 40599 4372
Diabetes mellitus with complications
25002 25003 25010 25011 25012 25013 25020 25021
25022 25023 25030 25031 25032 25033 25040 25041
25042 25043 25050 25051 25052 25053 25060 25061
25062 25063 25070 25071 25072 25073 25080 25081
25082 25083 25090 25091 25092 25093
Nutritional deficiencies
V121 260 261 262 2630 2631 2632 2638 2639 2640
2641 2642 2643 2644 2645 2646 2647 2648 2649 2650
2651 2652 2660 2661 2662 2669 267 2680 2681 2682
2689 2690 2691 2692 2693 2698 2699 7994
Gastrointestinal haemorrhage
4560 45620 5307 53082 53100 53101 53120 53121
53140 53141 53160 53161 53200 53201 53220 53221
53240 53241 53260 53261 53300 53301 53320 53321
53340 53341 53360 53361 53400 53401 53420 53421
53440 53441 53460 53461 5693 5780 5781 5789
Invasion of other structures
1974 1975 1976 1977 1978
Diverticulosis and diverticulitis
56200 56201 56202 56203 56210 56211 56212 56213
Other gastrointestinal disorders
V127 V1270 V1279 V416 V441 V442 V443 V444 V453
V473 V535 V551V552 V553 V554 5581 5582 5640 56400
56401 56402 56409 5641 5645 5647 5648 56481 56489
5649 5680 56881 56882 56889 5689 56981 56982
56983 56984 56985 56986 56989 5699 5790 5791 5792
5798 5799 7871 7872 7873 7874 7875 7876 7877 7879
78791 78799 7892 7893 78930 78931 78932 78933
78934 78935 78936 78937 78939 7894 78940 78941
78942
78943 78944 78945 78946 78947 78949 7899 7921
7934 7936
Fluid and electrolyte disorders
2760 2761 2762 2763 2764 2765 2766 2767 2768 2769
Cardiac dysrhythmias
4270 4271 4272 42731 42732 42760 42761 42769
42781 42789 4279 7850 7851
Congestive heart failure, no hypertensive
39891 4280 4281 42820 42821 42822 42823 42830
42831 42832 42833 42840
42841 42842 42843 4289
Malignant neoplasm of stomach:
1510 Cardia
1511 Pylorus
1512 Pyloric antrum
1513 Fundus of stomach
1514 Body of stomach
1519 Stomach, unspecified
Operations on lymphatic system
40.2 Simple excision of lymphatic structure
40.3 Regional lymph node excision
40.5 Radical excision of other lymph nodes
Incision and excision of stomach
43.5 Partial gastrectomy with anastomosis to oesophagus
(proximal gastrectomy)
43.6 Partial gastrectomy with anastomosis to duodenum
(Billroth I)
43.7 Partial gastrectomy with anastomosis to jejunum
(Billroth II)
43.8 Other partial gastrectomy
43.9 Total gastrectomyBMC Public Health 2009, 9:312 http://www.biomedcentral.com/1471-2458/9/312
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